Provided by Tiger Fintech (Singapore) Pte. Ltd.

Abbott Laboratories

138.96
+1.821.33%
Volume:3.62M
Turnover:500.40M
Market Cap:241.00B
PE:18.19
High:139.11
Open:137.10
Low:137.00
Close:137.14
Loading ...

Cadrenal Therapeutics Announces Collaboration Agreement with Abbott in Support of Pivotal Study of Tecarfarin in Patients with HeartMate 3™ LVAD

Business Wire
·
04 Mar

Abbott : Citigroup Raises Target Price to $160 From $135

THOMSON REUTERS
·
04 Mar

Is Abbott Laboratories' (NYSE:ABT) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Simply Wall St.
·
04 Mar

Goldman Sachs Adjusts Price Target on Abbott Laboratories to $154 From $138, Keeps Buy Rating

MT Newswires Live
·
04 Mar

Citi ups Abbott target, opens ‘negative catalyst watch’

TIPRANKS
·
04 Mar

Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4

StockStory
·
04 Mar

Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
04 Mar

AHCO vs. ABT: Which Stock Is the Better Value Option?

Zacks
·
04 Mar

Income Investing: Where to Find Safety and Yield in Dividend Stocks -- Barron's

Dow Jones
·
01 Mar

Abbott Laboratories Stock Rises Friday, Still Underperforms Market

Dow Jones
·
01 Mar

With 79% ownership of the shares, Abbott Laboratories (NYSE:ABT) is heavily dominated by institutional owners

Simply Wall St.
·
28 Feb

3 Reasons ABBV is Risky and 1 Stock to Buy Instead

StockStory
·
28 Feb

Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest

StockStory
·
28 Feb

Abbott (ABT) Stock Moves -0.07%: What You Should Know

Zacks
·
28 Feb

The major companies which have relocated to Texas, from Tesla to Chevron

businessinsider.com
·
28 Feb

Global Business Travel reports Q4 revenue $591M, consensus $589.16M

TIPRANKS
·
27 Feb